Volume 86, Issue 6 (June), 2022-6-1, Pages A3-e280

Articles in this issue:

1. Editorial board

2. Table of contents

3. Information for readers

4. JAAD Case Reports article list

5. Journal based CME instructions and information

6. Part I Antimicrobial resistance: Bacterial pathogens of dermatologic significance and implications of rising resistance

7. Antimicrobials and resistance part II: Antifungals, antivirals, and antiparasitics

8. Likelihood ratios

9. This Month in JAAD: June 2022

10. June 2022: Trichorrhexis nodosa of the beard associated with mask use

11. This Month in JAAD International: June 2022: Merkel cell carcinoma management and outcomes

12. Treating generalized pustular psoriasis: The path forward

13. Inhibition of tumor necrosis factor improves conventional steroid therapy for Stevens-Johnson syndrome/toxic epidermal necrolysis in a cohort of patients

14. Adjuvant radiotherapy may not significantly change outcomes in high-risk cutaneous squamous cell carcinomas with clear surgical margins: A systematic review and meta-analysis

15. Clinicoprognostic implications of head and neck involvement by mycosis fungoides: A retrospective cohort study

16. Treatments and outcomes of generalized pustular psoriasis: A cohort of 1516 patients in a nationwide inpatient database in Japan

17. Clinical characteristics and long-term outcome of 223 patients with mycosis fungoides at a single tertiary center in Korea: A 29-year review

18. Disease characteristics, prognosis, and response to therapy in patients with large-cell transformed mycosis fungoides: A single-center retrospective study

19. Real-life impact of immunologic tests to predict relapse after treatment cessation in patients with bullous pemphigoid: A French multicenter retrospective study

20. Identifying Brigham and Women's Hospital stage T2a cutaneous squamous cell carcinomas at risk of poor outcomes

21. Correlation of basal cell carcinoma subtype with histologically confirmed subclinical extension during Mohs micrographic surgery: A prospective multicenter study

22. Treatment of pediatric alopecia areata: A systematic review

23. American Academy of Dermatology Guidelines: Awareness of comorbidities associated with atopic dermatitis in adults

24. Antibiotic resistance in dermatology: The scope of the problem and strategies to address it

25. Presentation and management of diverse cutaneous reactions after cyclin-dependent kinase 4/6 inhibitor use

26. Extended dosing intervals of ixekizumab for psoriasis: A single-center, uncontrolled, prospective study

27. Prevalence of inflammatory bowel disease in patients with pyoderma gangrenosum: A population-based analysis

28. Granuloma annulare is not associated with solid-organ malignancies: A cohort study

29. The diagonal technique for alopecia biopsies

30. Annual Trends in Medicare Part D Prescription Claims for Vismodegib, 2013-2018

31. Efficacy of medical students’ virtual dermatology curriculum

32. Dermoscopic features of 61 skin lesions in xeroderma pigmentosum patients: A cross-sectional study

33. Seasonal burden of National Emergency Department visits due to hidradenitis suppurativa

34. Vismodegib efficacy in unresectable trichoblastic carcinoma: A multicenter study of 16 cases

35. Increased melanoma recurrence in patients with multiple primary invasive melanomas

36. Examining low rates of dermatology visits in solid organ transplant recipients

37. Drug-induced eosinophilic fasciitis: A dual pharmacovigilance analysis

38. Racial differences in sun-protective behaviors: A retrospective, cross-sectional analysis of the National Health and Nutrition Examination Survey (NHANES) 2003-2018

39. A population-based comparison of organ transplant recipients in whom cutaneous squamous cell develops versus those in whom basal cell carcinoma develops

40. Prevalence of potentially allergenic ingredients in products labeled for eczema care

41. Health-related domains of quality of life in pyoderma gangrenosum: A qualitative analysis

42. Merkel cell carcinoma patients with solid organ transplant or hematologic malignancy: Demographics, survival, and prognosticators

43. Neutrophil to lymphocyte ratio is predictive of severe complications and mortality in patients with dipeptidyl peptidase-4 inhibitor-associated bullous pemphigoid: A retrospective longitudinal observational study

44. Ultraviolet camera-aided sunscreen application in children: Demonstration of efficacy and receptivity

45. Sociodemographic determinants of teledermatology acceptability

46. Trends in utilization of reflectance confocal microscopy in the United States, 2017-2019

47. Efficacy of ruxolitinib cream in vitiligo by patient characteristics and affected body areas: Descriptive subgroup analyses from a phase 2, randomized, double-blind trial

48. Association between income and suspected nonmelanoma and melanoma skin cancers among participants of the American Academy of Dermatology's SPOT Skin Cancer screening program: A cross-sectional analysis

49. Trends in diversity of participants in dermatology clinical trials over time: A systematic review

50. The “spade sign” as a pathognomonic histopathologic feature of acne keloidalis: Analysis of 33 cases of cicatricial alopecia

51. Development and initial validation of a modified Sinclair scale for female pattern hair loss in men

52. Racial and ethnic disparities in inpatient health care utilization for mycosis fungoides: A cross-sectional analysis of the 2012-2017 National Inpatient Sample

53. Volume tumor impact on melanoma survival assessed using Breslow density

54. Cutaneous Langerhans cell histiocytosis in adults: A retrospective cohort study of adult patients presenting to a single academic cancer center between 2003 and 2017

55. Factors associated with the American Academy of Dermatology abstract publication: A multivariate analysis

56. Rosacea and subsequent diagnosis of venous thromboembolism: A large, urban academic center case-control study

57. Declining utilization of potentially inappropriate medications in older adults by dermatologists: A cross-sectional Medicare analysis

58. Association between psoriasis and rheumatoid arthritis in a nationally representative population in the United States

59. Necrobiosis lipoidica-associated cutaneous malignancy Download PDF

60. Mohs micrographic surgery for dermatofibrosarcoma protuberans in 7 patients aged 10 years and younger

61. Otorhinolaryngologic anomalies in children and young adults with congenital ichthyoses and keratinization disorders: Prospective assessment in a multidisciplinary clinic

62. Chemotherapy-induced alopecia in African American women: A literature review demonstrates a knowledge gap

63. Virtual reality memory palace: An innovative dermatology education modality

64. Cross-sectional analysis of scholarly work and mentor relationships in matched dermatology residency applicants

65. The safety of rituximab for the treatment of autoimmune blistering diseases: A systematic review

66. Comparison of the safety and efficacy of daylight photodynamic therapy and conventional photodynamic therapy for actinic keratoses: A systematic review demonstrating noninferiority

67. A report of 1290 pediatric hidradenitis suppurativa hospitalizations: A nationwide analysis from the Kids' Inpatient Database

68. Improving quality of teledermatology visits: The Skin-Know-Implement-Next checklist

69. Ethics of skin cancer treatment in a patient who continues with indoor tanning Download PDF

70. Puckered chin sign in systemic sclerosis

71. Topical tacrolimus for acne-related macular erythema to prevent atrophic scarring

72. The SH-flap: A modification of the bilateral advancement flap

73. A novel strategy of cardioid serial excision

74. Prepopulated consent forms in dermatologic surgery: Enhancing and explicating communication

75. Using a Mustarde-like backcut to maximize crescentic advancement flaps for large nasomalar defects

76. Simple vacuum compression dressing for skin graft

77. Lighting in dermatology using a ring light

78. Under-representation of racial and ethnic minorities in nail psoriasis randomized clinical trials: A call to action

79. Insights into the “fear factor” regarding terbinafine-associated hepatoxicity in an assessment of online information Download PDF

80. From the Cochrane Library: Interventions for mucous membrane pemphigoid and epidermolysis bullosa acquisita

81. Addressing diversity in dermatology: Implementation of formalized allyship

82. Multipronged initiatives for addressing disparities in representation in dermatology

83. Biotin beware: Perils of biotin supplementation: Response to: “The epidemiology, impact, and diagnosis of micronutrient nutritional dermatoses. Part 2: B-complex vitamins”